Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jmwhitha
    Senior Member
    • Mar 2013
    • 107

    #1

    HIDATA to LOWDATA status and now false p value Cuffdiff isoform_exp.diff

    Hello SeqAnswers community,

    When I first tried to run cuffdiff, I found that I had many HIDATA status for my isoform_exp.diff. After running it with 10X the default max-bundle-frags, I didn't have any HIDATA status left. However, I have many LOWDATA status now.

    It's very strange. I am looking at a particular gene right now that has 167095 count but has a LOWDATA status while the same gene in the other condition has a OK status (821 count). Before adjusting the max-bundle-frags, they both had HIDATA.

    Clearly, there is differential expression, but cuffdiff isoform_exp.diff says "no".
    test_id = TCONS_00000809
    gene_id = XLOC_000295
    gene = Doesn't matter
    locus = Doesn't matter
    sample_1 = Cond1
    sample_2 = Cond2
    status = LOWDATA
    value_1 = 7012.28
    value_2 = 1.07803
    log2(fold_change) = -12.6673
    test_stat = 0
    p_value = 1
    q_value = 1
    significant = no

    Why is it giving these high p and q values?

    Thank you and God bless,
    Jason
  • jmwhitha
    Senior Member
    • Mar 2013
    • 107

    #2
    I take that back, actually I changed the max-bundle-frags to 70X the default.

    Please, if anyone knows why my p-values are defaulting to one and my test_stat is defaulting to 0, I would greatly appreciate the information.

    Thank you!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Working...